Alnylam Pharmaceuticals, Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
ALNY Nasdaq 2834 http://www.alnylam.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Alnylam Pharmaceuticals, Inc.

5 Top Drug/Biotech Merger & Acquisition Targets for 2019 - Dec 10th, 2018 5:58 am
Alnylam Announces Settlement of Litigation with Silence Therapeutics - Dec 10th, 2018 12:00 am
Hedge Funds Are Dumping Alnylam Pharmaceuticals, Inc. (ALNY) - Dec 8th, 2018 10:44 am
[$$] Moderna IPO Marks Milestone for New Biotech Market - Dec 7th, 2018 4:11 pm
Moderna’s Rich IPO Valuation Raises the Stakes for Investors - Dec 7th, 2018 10:20 am
Recent Analysis Shows Microsoft, Alnylam Pharmaceuticals, F5 Networks, Green Plains Partners LP, Itron, and Progress Software Market Influences — Renewed Outlook, Key Drivers of Growth - Dec 6th, 2018 6:15 am
Alnylam Provides R&D Updates and Announces 2019 Product and Pipeline Goals at R&D Day - Dec 6th, 2018 5:00 am
Today's Research Reports on Trending Tickers: Alnylam Pharmaceuticals and Sage Therapeutics - Nov 30th, 2018 4:55 am
Why Pfizer Could Lead These Two Biotech Stocks In Tackling Amyloidosis - Nov 29th, 2018 3:30 pm
Alnylam CEO on drug prices: Has to be some type of reward... - Nov 29th, 2018 1:28 pm
Alnylam to Webcast R&D Day - Nov 29th, 2018 6:00 am
Alnylam, Vir Begin Phase I/II Study on Hepatitis B Candidate - Nov 27th, 2018 1:41 pm
Why Alnylam Pharmaceuticals Inc’s (NASDAQ:ALNY) CEO Pay Matters To You - Nov 27th, 2018 12:48 pm
DEADLINE TODAY: The Schall Law Firm Announces it is Investigating Claims Against Alnylam Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm - Nov 26th, 2018 6:00 am
Vir Biotechnology and Alnylam Pharmaceuticals Initiate Phase 1/2 Study of VIR-2218 - Nov 26th, 2018 5:00 am
DEADLINE TOMORROW: The Schall Law Firm Announces it is Investigating Claims Against Alnylam Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm - Nov 25th, 2018 4:07 pm
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of TGTX, ALNY, CHGG, CWH and DY - Nov 25th, 2018 8:17 am
ALNY NOV 26 DEADLINE: Rosen Law Firm Reminds Alnylam Pharmaceuticals, Inc. Investors of Important Deadline in Class Action - Nov 25th, 2018 7:00 am
MONDAY DEADLINE: Kaskela Law LLC Announces Class Action Lawsuit Against Alnylam Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm – ALNY - Nov 25th, 2018 6:00 am